When Elise Felicione tried to design a clinical trial for a supplement, 5 things got in the way. It’s a lesson for the ...

By Dr. Priyom Bose, Ph.D. Inviting adults to colorectal cancer screening at age 60 shifts diagnoses to earlier stages without ...

Qure’s AMT-130 faces FDA efficacy doubts after 12-month data. QURE's upside now hinges on political pressure. Read here for ...

This is a shame, because regular exercise is really beneficial. It can control high blood pressure, improve mental health and reduce falls among older adults. A review of 187 randomized controlled ...

Daily intake of avocado and mango may improve endothelial function in people with prediabetes, according to new data ...

This transition is explored in “Embodied Artificial Intelligence in Healthcare: A Systematic Review of Robotic Perception, ...

A 5-day amoxicillin challenge was feasible for evaluating delayed penicillin allergy, with more than 80% of participants completing the protocol; immune‑mediated reactions were uncommon but occurred ...

A novel first-in-class gene-regulation therapy for Dravet syndrome was associated with large reductions in seizures and improved functional outcomes in children with Dravet syndrome. Results from ...

PRAME Cell Therapy: Global, randomized, controlled Phase 3 trial, SUPRAME, in previously treated advanced melanoma ongoing; anzu-cel received Orphan Drug Designation from the FDA for the treatment of ...

News headlines often compress complex science into a simple storyline: If two things are happening at the same time, one must ...

A psychiatrist explains why Internal Family Systems is having a moment, despite its lack of evidence.

Company is well positioned following positive FDA Type B meeting outcome, fully enrolled Phase 2 trial for its lead clinical program, and recent $5 million public offering, as commercial operation ...